Yusuke Naito

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Clinical Practice

Prognostic Factors

Glycemic Control

Metabolic Syndrome

Top Venues

Expert opinion on drug safety

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Kohei Kaku, Yayoi Nakayama, Junko Yabuuchi, Yusuke Naito, Keizo Kanasaki
Safety and effectiveness of empagliflozin in clinical practice as monotherapy or with other glucose-lowering drugs in Japanese patients with type 2 diabetes: subgroup analysis of a 3-year post-marketing surveillance study. Expert opinion on drug safety (2023)
Takashi Kadowaki, Fumiko Yamamoto, Yusuke Taneda, Yusuke Naito, Douglas Clark, Søren S Lund, Tomoo Okamura, Kohei Kaku
Effects of anti-diabetes medications on cardiovascular and kidney outcomes in Asian patients with type 2 diabetes: a rapid evidence assessment and narrative synthesis. Expert opinion on drug safety 20 (6) (2021)
Tomohiro Ito, Yusuke Naito, Naoki Shimmoto, Kaori Ochiai, Naoyuki Hayashi, Tomoo Okamura
Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance. Expert opinion on drug safety 20 (3) (2020)
Yuichiro Yamada, Masayuki Senda, Yusuke Naito, Masahiro Tamura, Daisuke Watanabe, Yujin Shuto, Yoshihisa Urita
Reduction of postprandial glucose by lixisenatide vs sitagliptin treatment in Japanese patients with type 2 diabetes on background insulin glargine: A randomized phase IV study (NEXTAGE Study). Diabetes, obesity & metabolism 19 (9) (2017)